Finance.Foundation
Comparison · seed-0.7 · marketcap-1 · 2026-08-30

AbbVie (ABBV) vs Roche (ROG)

AbbVie (ABBV) and Roche (ROG) side by side: both in Healthcare, listed on New York Stock Exchange and SIX Swiss Exchange. AbbVie is the larger of the two by approximate market capitalization (about 1.2×).

FieldAbbVieRoche
Legal nameAbbVie Inc.Roche Holding AG
TickerABBVROG
ExchangeNew York Stock Exchange XNYSSIX Swiss Exchange XSWX
JurisdictionUnited StatesSwitzerland
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals and diagnostics
Market cap ≈$451.5bn$368.3bn
Founded20131896
Reporting currencyUSDCHF
LEIFR5LCKFTG8054YNNRU85549300U41AUUVOAAOB37
ISINUS00287Y1091CH0012032048
FIGIBBG0025Y4RZ3BBG001SD12S2
Index membershipS&P 500—
Held by (covered funds)——

AbbVie

Large pharmaceutical company spun off from Abbott in 2013, with immunology blockbusters Skyrizi and Rinvoq succeeding Humira, plus the Allergan aesthetics portfolio (Botox).

Full profile →

Roche

Basel-based healthcare group founded in 1896, the world leader in in-vitro diagnostics and a top oncology drugmaker. The founding Hoffmann and Oeri families still hold a controlling voting stake.

Full profile →

Market caps are computed from each issuer's own filed share count times the close on 2026-08-28, not copied from a vendor; LEI from GLEIF (CC0), ISIN read from each issuer's own primary listing document with its ISO 6166 check digit validated, FIGI from OpenFIGI, MIC from the ISO 10383 registry — full provenance on Sources. Not real-time, not investment advice. Both sides as data: /api/v1/companies/abbvie · /api/v1/companies/roche